Saturday, May 10, 2025

Life Sciences

MasterControl
Document Summarizer is part of a suite of industry-leading tools from MasterControl assisting in streamlining quality management processes for life sciences and regulated industries. MasterControl, a leading provider of quality management and next-generation manufacturing execution software for life sciences, announced general availability release of its AI-powered Document Summarizer. The new...
Latent Labs
Latent Labs, the company building AI foundation models to make biology programmable, emerged from stealth with $50M in total funding to accelerate their progress and partnerships. The company was founded by Dr Simon Kohl, previously a co-lead of DeepMind’s protein design team and a senior research scientist on DeepMind’s AlphaFold2,...
Tempus AI
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a new collaboration with the Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development of innovative treatment options for patients with follicular lymphoma...
Lindus Health
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials, has announced their collaboration with the Clinical Data Interchange Standards Consortium (CDISC), to accelerate the generation of standardized concepts using AI. CDISC is an organization that develops data standards to streamline the collection, sharing, and analysis of clinical trial...
SandboxAQ
Alliance to add focus for Large Quantitative Models (LQMs) which are the new frontier in AI with applications in biopharma, energy and other sectors SandboxAQ announced it has expanded its relationship with Deloitte to offer SandboxAQ's AI LQM simulation products and solutions along with Deloitte's services capabilities to organizations worldwide. SandboxAQ's AQBioSim...
Capgemini
Capgemini announced a new generative AI-driven methodology for protein engineering that uses a specialized protein large language model (pLLM) to predict the most effective protein variants. With a patent pending, this novel approach will help accelerate the advancement of the global bioeconomy and drive critical scientific breakthroughs across industries...
myTomorrows
With the goal of streamlining industry-wide clinical trial recruitment and improving patient outcomes, myTomorrows unveils its next major AI-powered technological advancement. myTomorrows, a global health technology company connecting patients and physicians with all possible pre-approval treatment options, announced the launch of its next-generation AI platform. Designed to streamline clinical trial...
Inspire
Inspire, the leading patient network and real-world evidence solutions provider, announced  the launch of Patient Voice AI, a groundbreaking product designed to revolutionize how life sciences organizations gather and leverage patient insights. Built on Inspire’s unique dataset of over 12 million authentic patient and caregiver discussions, Patient Voice AI...
BioAro
Transforming Genomic Medicine with Unprecedented Speed, Accuracy, and Accessibility - PanOmiQ Sets a New Standard with Analysis Time from VCF Files Under 5 Minutes, and Less Than 2 hrs for FASTQ Files BioAro, a global leader in precision health and genomics, will unveil its groundbreaking AI-powered PanOmiQ platform at the...
PhaseV
PhaseV, a pioneer in software and machine learning (ML) for clinical trial optimization, announced it has entered a strategic partnership with Alimentiv Inc., a global GI (gastrointestinal) contract research organization (CRO), to support the optimal design and execution of advanced adaptive clinical trials for a range of GI conditions....